Evidence map›Paper›PMID 12199144›Full record

ArticleChromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology2002

Active, but not inactive, human centromeres display topoisomerase II activity in vivo.

Claus L Andersen, Annelise Wandall, Eigil Kjeldsen, Christian Mielke, Jørn Koch

Abstract read
PubMed Publisher
In one paragraph

Article in Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. DNA strand breaks at centromeres: Friend or foe?Seminars in cell & developmental biology · 2024
    Review
  2. Article
  3. Review
  4. Review
  5. Site-Specific Cleavage by Topoisomerase 2: A Mark of the Core Centromere.International journal of molecular sciences · 2018
    Article
  6. Non-Catalytic Roles of the Topoisomerase IIα C-Terminal Domain.International journal of molecular sciences · 2017
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Progressive proximal expansion of the primate X chromosome centromere.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  17. Topoisomerase II cleavage activity within the human D11Z1 and DXZ1 alpha-satellite arrays.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2005
    Article
  18. Article
  19. Article
  20. Topoisomerase II: untangling its contribution at the centromere.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2004
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Claus L AndersenCancercytogenetics Laboratory, Tage Hansens Gade 2, DK-8000 Aarhus C, Denmark.
Annelise Wandall
Eigil Kjeldsen
Christian Mielke
Jørn Koch
Chr. Hansen (Denmark) · DKAarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eukaryotic centromeres are composed of centromere DNA and the multiple proteins directly or indirectly associated with it. One important DNA-binding protein in the centromere is DNA topoisomerase II (topo II). In the genome in general, topo II has two functions, one structural and one enzymatic, the latter catalyzing DNA strand-passage reactions. It has been demonstrated that topo II accumulates at centromeres during the first part of mitosis, and disappears again at anaphase, but it has not been clear whether it serves a structural or an enzymatic function at the centromere. To investigate this issue, we developed the topo II-induced self-primed in situ assay (Topo-SPRINS). In this assay, DNA breaks created by topo II are stabilized with the topo II inhibitor VM-26 in vivo, and used as 'primers' for localized DNA synthesis in vitro. The assay revealed that topo II has enzymatic activity at mitotic centromeres and that the activity is relatively constant across centromeres. Furthermore, the activity was observed at a neocentromere, and, in multicentric chromosomes, the activity was restricted to the active centromere. The topo II activity is thus selectively present at functioning centromeres, indicating that it plays a role in mitotic centromere function.

Indexed as

CentromereDNA Topoisomerases, Type IIEnzyme InhibitorsGenome, HumanHumansIn Situ Hybridization, FluorescenceKaryotypingTeniposideTopoisomerase II InhibitorsDNA Topoisomerases, Type IIEnzyme InhibitorsTeniposideTopoisomerase II Inhibitors

Identifiers

PMID12199144
OpenAlexW1834163804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.